Type 2 diabetes drug can successfully reduce symptoms associated with tuberous sclerosis complex
A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital […]
» Read moreHome »
A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital […] (HealthDay)—Metformin use may promote a survival benefit in individuals with post-pancreatitis diabetes mellitus (PPDM), but not pancreatic cancer-related diabetes (PCRD), […]
Metformin trial dramatically reduces seizures in tuberous sclerosis
Metformin may cut mortality risk in post-pancreatitis diabetes
